X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (62) 62
humans (56) 56
rheumatology biologics register (46) 46
tumor necrosis factor-alpha - antagonists & inhibitors (43) 43
rheumatology (39) 39
female (34) 34
arthritis (33) 33
rheumatology-biologics-register (31) 31
male (30) 30
middle aged (30) 30
adult (28) 28
british society (28) 28
etanercept (28) 28
anti-tnf therapy (25) 25
infliximab (25) 25
adalimumab (22) 22
antirheumatic agents - adverse effects (21) 21
risk (20) 20
treatment outcome (20) 20
british-society (19) 19
arthritis, rheumatoid - drug therapy (18) 18
rheumatoid arthritis (18) 18
antirheumatic agents - therapeutic use (17) 17
tumor necrosis factor (17) 17
risk factors (15) 15
ankylosing spondylitis (14) 14
aged (13) 13
ankylosing-spondylitis (13) 13
psoriasis (12) 12
psoriatic arthritis (12) 12
spondylitis, ankylosing - drug therapy (12) 12
antibodies, monoclonal - therapeutic use (11) 11
arthritis, psoriatic - drug therapy (11) 11
psoriatic-arthritis (11) 11
retrospective studies (11) 11
rheumatoid factor (11) 11
tuberculosis (11) 11
abridged index medicus (10) 10
necrosis factor therapy (10) 10
pharmacology & pharmacy (10) 10
severity of illness index (10) 10
antibodies, monoclonal - adverse effects (9) 9
antibodies, monoclonal, humanized - adverse effects (9) 9
cancer (9) 9
health aspects (9) 9
infections (9) 9
modifying antirheumatic drugs (9) 9
placebo-controlled trial (9) 9
safety (9) 9
tumor necrosis factor-tnf (9) 9
antitumor-necrosis-factor (8) 8
double-blind (8) 8
drug therapy (8) 8
follow-up studies (8) 8
immunology (8) 8
infection (8) 8
research (8) 8
risk assessment (8) 8
therapy (8) 8
tnf (8) 8
adalimumab - therapeutic use (7) 7
analysis (7) 7
antibodies, monoclonal, humanized - therapeutic use (7) 7
biological products - adverse effects (7) 7
care and treatment (7) 7
dermatology (7) 7
immunoglobulin g - therapeutic use (7) 7
medicine, general & internal (7) 7
monoclonal antibodies (7) 7
receptors, tumor necrosis factor - therapeutic use (7) 7
registries (7) 7
serious infections (7) 7
active ankylosing-spondylitis (6) 6
antirheumatic agents - administration & dosage (6) 6
biological products - therapeutic use (6) 6
crohns-disease (6) 6
incidence (6) 6
infliximab - therapeutic use (6) 6
methotrexate (6) 6
quality-of-life (6) 6
serious infection (6) 6
spondylitis (6) 6
tnf inhibitors (6) 6
treatment (6) 6
tumor necrosis factor inhibitors (6) 6
tumor-necrosis-factor (6) 6
young adult (6) 6
anti-tnf (5) 5
cohort studies (5) 5
disease (5) 5
etanercept - therapeutic use (5) 5
factor antagonists (5) 5
factor-alpha therapy (5) 5
immunoglobulin g - adverse effects (5) 5
immunosuppressive agents - adverse effects (5) 5
juvenile idiopathic arthritis (5) 5
long-term safety (5) 5
malignancy (5) 5
medical research (5) 5
medicine & public health (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of the Rheumatic Diseases, ISSN 0003-4967, 11/2011, Volume 70, Issue 11, pp. 1914 - 1920
Journal Article
Journal Article
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2013, Volume 70, Issue 1, pp. 168 - 177
Journal Article
Rheumatology (Oxford, England), ISSN 1462-0324, 07/2016, Volume 55, Issue 7, pp. 1337 - 1339
Catastrophic antiphospholipid syndrome is associated with excessive complement activation explaining the clinical efficacy of complement inhibitory treatment. 
RHEUMATOLOGY BIOLOGICS REGISTER | RISK | RHEUMATOLOGY | ARTHRITIS | SHINGLES | BRITISH SOCIETY | Rheumatology: 759 | treatment | VDP | APS | pathophysiology | Eculizumab | clinical efficacy | Catastrophic antiphospholipid syndrome | Clinical medical disciplines: 750 | CAPS | Medical disciplines: 700 | Letters to the Editor
Journal Article
Archives of Medical Science, ISSN 1734-1922, 12/2014, Volume 10, Issue 6, pp. 1175 - 1185
Journal Article
Journal Article